secwatch.observer — SEC 8-K summary
======================================

Issuer:     EKSO BIONICS HOLDINGS, INC. (CHRN)
CIK:        0001549084
Form:       8-K
Filed at:   2023-06-12T23:59:59+00:00
Accession:  0001104659-23-070425
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ekso Bionics removes $6.75 floor from ATM offering; shareholders approve share plan increase
--------------------------------------------------------------------------------

- Amended at-the-market offering agreement with H.C. Wainwright to remove $6.75 per share floor, effective June 12, 2023.
- Prior ATM sales: 77,594 shares at avg $10.72 for $791,217 net proceeds; $6.67M remains available.
- Shareholders approved 2014 Equity Incentive Plan amendment, increasing authorized shares from 2,524,286 to 3,724,286.
- All five director nominees elected; advisory say-on-pay passed with ~4.1M For vs 293K Against.
- Ratified WithumSmith+Brown as independent auditor for FY2023 with ~7.0M For votes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1549084/000110465923070425/0001104659-23-070425-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1549084/000110465923070425/tm2318337d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-070425

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer